Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at radiotherapy to the chest after chemotherapy and rituximab for primary mediastinal large B cell lymphoma (IELSG 37)

Overview

Cancer types:

Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 3

Details

This trial is trying to find the best way to treat a rare type of non Hodgkin lymphoma called primary mediastinal large B cell lymphoma. This trial is supported by Cancer Research UK.

Recruitment start: 1 November 2013

Recruitment end: 31 July 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Andrew Davies

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

International Extranodal Lymphoma Study Group (IELSG)

NIHR Clinical Research Network: Cancer

Southampton Clinical Trials Unit

University Hospital Southampton NHS Foundation Trust

Other information

This is Cancer Research UK trial number CRUK/12/040.

Last reviewed: 11 Sept 2019

CRUK internal database number: 10554

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.